SUMOylation mediates the disassembly of the Smad4 nuclear export complex via RanGAP1 in KELOIDS
- J Cell Mol Med. 2023 Mar 14. doi: 10.1111/jcmm.17216.
- 1. Department of Plastic and Reconstructive Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
- 2. Ningbo Hwamei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, China.
- 3. Department of Plastic Surgery, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
Sentrin/small ubiquitin-like modifier (SUMO) has emerged as a powerful mediator regulating biological processes and participating in pathophysiological processes that cause human diseases, such as Cancer, myocardial fibrosis and neurological disorders. Sumoylation has been shown to play a positive regulatory role in keloids. However, the sumoylation mechanism in keloids remains understudied. We proposed that sumoylation regulates keloids via a complex. RanGAP1 acted as a synergistic, functional partner of SUMOs in keloids. Nuclear accumulation of SMAD4, a TGF-β/Smad pathway member, was associated with RanGAP1 after SUMO1 inhibition. RanGAP1*SUMO1 mediated the nuclear accumulation of SMAD4 due to its impact on nuclear export and reduction in the dissociation of SMAD4 and CRM1. We clarified a novel mechanism of positive regulation of sumoylation in keloids and demonstrated the function of sumoylation in SMAD4 nuclear export. The NPC-associated RanGAP1*SUMO1 complex functions as a disassembly machine for the export receptor CRM1 and SMAD4. Our research provides new perspectives for the mechanisms of keloids and nucleocytoplasmic transport.
-
Cat. No.Product NameDescriptionTargetResearch Area
-